It is estimated that up to 14% of patients with HIV have diabetes mellitus (DM), which is a determinant risk factor for the development of cardiovascular disease [1]. The therapeutic regimen is the same as that recommended in clinical practice guidelines such as the American Diabetes Association (ADA) and the European Diabetes Association (EASD) [2].
